116 related articles for article (PubMed ID: 2174003)
1. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R
Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
3. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
4. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
Shigemasa C; Kouchi T; Yoshida A; Mashiba H
J Med; 1991; 22(3):187-93. PubMed ID: 1663149
[TBL] [Abstract][Full Text] [Related]
5. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
Zacharieva S; Matrosov P; Stoeva I; Kirilov G
Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
[TBL] [Abstract][Full Text] [Related]
8. Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
J Endocrinol Invest; 1988 Apr; 11(4):261-5. PubMed ID: 2970500
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
10. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
[TBL] [Abstract][Full Text] [Related]
11. Plasma ACTH, cortisol and aldosterone concentrations in chronically cannulated ovine fetuses and in lambs injected with ovine corticotropin releasing factor.
Pradier P; Dalle M; Davicco MJ; Lefaivre J; Barlet JP; Delost P
J Dev Physiol; 1985 Aug; 7(4):259-68. PubMed ID: 2995476
[TBL] [Abstract][Full Text] [Related]
12. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
[TBL] [Abstract][Full Text] [Related]
13. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
14. Plasma beta-endorphin levels in primary aldosteronism.
Griffing GT; McIntosh T; Berelowitz B; Hudson M; Salzman R; Manson JA; Melby JC
J Clin Endocrinol Metab; 1985 Feb; 60(2):315-9. PubMed ID: 2981243
[TBL] [Abstract][Full Text] [Related]
15. Effect of naloxone on the hormone response to CRF in normal man.
Conaglen JV; Donald RA; Espiner EA; Livesey JH; Nicholls MG
Endocr Res; 1985; 11(1-2):39-44. PubMed ID: 2995021
[TBL] [Abstract][Full Text] [Related]
16. Effects of proopiomelanocortin peptides and angiotensin II on steroidogenesis in isolated aldosteronoma cells.
Pham-Huu-Trung MT; Bogyo A; de Smitter N; Girard F
J Clin Endocrinol Metab; 1985 Sep; 61(3):467-71. PubMed ID: 2991320
[TBL] [Abstract][Full Text] [Related]
17. Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.
Güllner HG; Nicholson WE; Gill JR; Orth DN
J Clin Endocrinol Metab; 1983 Apr; 56(4):853-5. PubMed ID: 6300169
[TBL] [Abstract][Full Text] [Related]
18. Pituitary and adrenal responses to ovine corticotropin releasing factor and vasopressin injected into young and adult guinea-pigs.
Pradier P; Tournaire C; Dalle M
J Dev Physiol; 1990 Sep; 14(3):163-9. PubMed ID: 1966108
[TBL] [Abstract][Full Text] [Related]
19. Effect of sandostatin on CRF-stimulated secretion of ACTH, beta-lipotropin and beta-endorphin.
Invitti C; Pecori Giraldi F; Dubini A; Piolini M; Cavagnini F
Horm Metab Res; 1991 May; 23(5):233-5. PubMed ID: 1651895
[TBL] [Abstract][Full Text] [Related]
20. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.
Rossi GP; Ganzaroli C; Miotto D; De Toni R; Palumbo G; Feltrin GP; Mantero F; Pessina AC
J Hypertens; 2006 Feb; 24(2):371-9. PubMed ID: 16508586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
